Search results for: 'Sick Care to Well Care'

Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...

This research service analyses the IVD in Korea, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

This research service analyses the IVD in China, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

03 Apr 2018  |  Asia Pacific  |  Market Outlook

Asia-Pacific Healthcare Outlook, 2018

The Year of Digital Innovation in Asia-Pacific

Infographics

×

The healthcare industry in Asia-Pacific (APAC) is expected to grow at 12.5% in 2018, making it one of the fastest growing regions in the world, as the global healthcare economy averages an annual growth rate of 4.8%. This positive growth is fuelled by increasing adoption of technology, innovative healthcare access programs, and delivery of care out...

This research service analyzes the IVD market in Australia strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, self-monitoring of blood gl...

This research service analyses the IVD market in Taiwan strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular testing, SMBG, and point-of-care testing, a...

This research service includes a detailed analysis of the medical devices distribution landscape in Vietnam, Indonesia, Thailand, and South Korea and profiles of five major distributors in each country. Corporate information, customer details, and competitive analysis of each distributor have been provided. Corporate information includes details ab...

The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry ...

Growing demand for healthcare services has created opportunities for growth and expansion in Asia-Pacific. In some countries, healthcare services companies are expanding out of their home ground, while others are strengthening and increasing their local capacity to serve the increasing demand in emerging markets. This profiling of the top 50 health...